Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 4Unknown 2Recruiting 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2Lymphoid 1Breast 1

Conditions

Keratosis, Actinic 2Psoriasis 1Lymphoma, Follicular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × calcipotriene × Clear all
NCT01582932 2019-01-22

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

Mayne Pharma International Pty Ltd

Phase 1 Completed
36 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT00656019 2017-12-02

Development of Vitamin D as a Therapy for Breast Cancer - Phase 2

Stanford University

Phase 2 Completed
63 enrolled 8 charts
Breast

Breast Neoplasms

NCT02976727 2016-11-29

Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis

Dong-A University

Phase 1 Completed
48 enrolled
Dermatologic

Keratosis, Actinic

NCT02019355 2016-05-19

AK

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
132 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡